Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers (vol 4, pg 1059, 2018)

被引：0
|
作者：
Kotsopoulos, J.
Gronwald, J.
Karlan, B.
机构：
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 08期
关键词：
D O I：
10.1001/jamaoncol.2018.1995
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1139 / 1139
页数：1
相关论文
共 50 条
  • [21] Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy
    Ingrid E. Fakkert
    Liesbeth Jansen
    Kees Meijer
    Theo Kok
    Jan C. Oosterwijk
    Marian J. E. Mourits
    Geertruida H. de Bock
    Breast Cancer Research and Treatment, 2011, 129 : 157 - 164
  • [22] RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Response
    Kotsopoulos, Joanne
    Sun, Ping
    Narod, Steven
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (10):
  • [23] The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers.
    Metcalfe, Kelly A.
    Lynch, Henry T.
    Snyder, Carrie L.
    Foulkes, William
    Tung, Nadine M.
    Kim-Sing, Charmaine
    Olopade, Olufunmilayo I.
    Eisen, Andrea
    Rosen, Barry
    Sun, Ping
    Narod, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers
    Neda Stjepanovic
    Jan Lubinski
    Pal Moller
    Susan Randall Armel
    William D. Foulkes
    Nadine Tung
    Susan L. Neuhausen
    Joanne Kotsopoulos
    Ping Sun
    Sophie Sun
    Andrea Eisen
    Steven A. Narod
    Breast Cancer Research and Treatment, 2021, 187 : 515 - 523
  • [25] Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers
    Stjepanovic, Neda
    Lubinski, Jan
    Moller, Pal
    Armel, Susan Randall
    Foulkes, William D.
    Tung, Nadine
    Neuhausen, Susan L.
    Kotsopoulos, Joanne
    Sun, Ping
    Sun, Sophie
    Eisen, Andrea
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 515 - 523
  • [26] Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers
    Fakkert, Ingrid E.
    Mourits, Marian J. E.
    Jansen, Liesbeth
    van der Kolk, Dorina M.
    Meijer, Kees
    Oosterwijk, Jan C.
    van der Vegt, Bert
    Greuter, Marcel J. W.
    de Bock, Geertruida H.
    CANCER PREVENTION RESEARCH, 2012, 5 (11) : 1291 - 1297
  • [27] Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers
    Bar Sade, RB
    Chetrit, A
    Figer, A
    Papa, MZ
    Flex, D
    Rizel, S
    Friedman, E
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (05) : 650 - 655
  • [28] Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
    Antonis C Antoniou
    Andrew Shenton
    Eamonn R Maher
    Emma Watson
    Emma Woodward
    Fiona Lalloo
    Douglas F Easton
    D Gareth Evans
    Breast Cancer Research, 8
  • [29] Breast cancer risk among male BRCA1 and BRCA2 mutation carriers
    Tai, Yu Chuan
    Domchek, Susan
    Parmigiani, Giovanni
    Chen, Sining
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (23) : 1811 - 1814
  • [30] Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antoniou, Antonis C.
    Shenton, Andrew
    Maher, Eamonn R.
    Watson, Emma
    Woodward, Emma
    Lalloo, Fiona
    Easton, Douglas F.
    Evans, D. Gareth
    BREAST CANCER RESEARCH, 2006, 8 (06)
12345